Home Monitoring of Retinal Sensitivity on a Tablet Devicein Intermediate Age-Related Macular Degeneration
Initiatives
-
We determine the feasibility of using a home-based tablet device tomonitor retinal sensitivity (RS) in intermediate age-related macular degeneration(iAMD), the benefits of weekly reminders, and the comparison with clinic-based.
Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
- Start Year
- 2018
- End Year
- 2018
- Funding
- Supported by The National Health and MedicalResearch Council), Principal Research Fellowship(GNT1103013) and Early Career Fellowship(#1104985, ZW). The Centre for Eye ResearchAustralia (CERA) receives Operational InfrastructureSupport from the Victorian Government
Design
- Study design
- Patients' cohort
Marker Paper
Adams M, Ho CYD, Baglin E, et al. Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration. Transl Vis Sci Technol. 2018;7(5):32. Published 2018 Oct 29. doi:10.1167/tvst.7.5.32
PUBMED 30386684
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 38
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |
Timeline
Patients with iAMD
Of 38 participants (mean age, 70.3 years) with iAMD enrolled in the study.
(iAMD) - intermediate age-related macular degeneration (iAMD).
Selection Criteria
- Minimum age
-
50
- Newborns
- Twins
- Ethnic Origin
-
- Health Status
-
- Exclusion criteria were late AMD in either eye; otherocular diseases that could have influenced retinalsensitivity, such as glaucoma, significant cataracts,corneal pathology, diabetes, uncontrolled hyperten-sion, amblyopia, neurological or systemic diseaseaffecting vision; or any medication known to affectretinal function. Participants also were excluded ifthey had any physical and/or mental impairmentpreventing them from participating in this study or aninability to sign a consent form
Recruitment
- Sources of recruitment
-
- Specific population
- Specific Population
-
- Clinic patients
Number of participants
- Number of participants
- 38
- Number of participants with biosamples
Data Collection Event
A customized test for tablets was designed to measure RS (within central 28) in individuals with iAMD at weekly intervals in their home, with remote datacollection. Half of the participants were randomized to receive weekly test reminders.
- Start Date
-
2018
- End Date
-
2018
- Data sources
-
-
Mobile data collection
- Smartphone apps
- Tablet/laptop
-
Mobile data collection